These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9459346)
1. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254. DeLa Cadena RA; Kunapuli SP; Walz DA; Colman RW Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346 [TBL] [Abstract][Full Text] [Related]
2. Platelet thrombospondin interactions with human high and low molecular weight kininogens. DeLa Cadena RA; Wyshock EG; Kunapuli SP; Schultze RL; Miller M; Walz DA; Colman RW Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360 [TBL] [Abstract][Full Text] [Related]
4. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Meloni FJ; Gustafson EJ; Schmaier AH Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948 [TBL] [Abstract][Full Text] [Related]
5. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin. Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707 [TBL] [Abstract][Full Text] [Related]
6. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin. Baglia FA; Walsh PN Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373 [TBL] [Abstract][Full Text] [Related]
7. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets. Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158 [TBL] [Abstract][Full Text] [Related]
8. Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. Jiang YP; Muller-Esterl W; Schmaier AH J Biol Chem; 1992 Feb; 267(6):3712-7. PubMed ID: 1740422 [TBL] [Abstract][Full Text] [Related]
9. Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays. Majluf-Cruz A; Manns JM; Uknis AB; Yang X; Colman RW; Harris RB; Frazier W; Lawler J; DeLa Cadena RA J Lab Clin Med; 2000 Oct; 136(4):292-302. PubMed ID: 11039850 [TBL] [Abstract][Full Text] [Related]
10. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin. Scandura JM; Ahmad SS; Walsh PN Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425 [TBL] [Abstract][Full Text] [Related]
11. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. DeLa Cadena RA; Colman RW Protein Sci; 1992 Jan; 1(1):151-60. PubMed ID: 1304876 [TBL] [Abstract][Full Text] [Related]
12. Rapid direct determination of low and high molecular weight kininogen in human plasma by Particle Concentration Fluorescence Immunoassay (PCFIA). Scott CF; Shull B; Müller-Esterl W; Colman RW Thromb Haemost; 1997 Jan; 77(1):109-18. PubMed ID: 9031459 [TBL] [Abstract][Full Text] [Related]
13. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies. Sugi T; Mclntyre JA Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270 [TBL] [Abstract][Full Text] [Related]
14. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine. Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of vitronectin-mediated haptotaxis and haptoinvasion of MG-63 cells by domain 5 (D5(H)) of human high-molecular-weight kininogen and identification of a minimal amino acid sequence. Kamiyama F; Maeda T; Yamane T; Li YH; Ogukubo O; Otsuka T; Ueyama H; Takahashi S; Ohkubo I; Matsui N Biochem Biophys Res Commun; 2001 Nov; 288(4):975-80. PubMed ID: 11689005 [TBL] [Abstract][Full Text] [Related]
16. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain. Hasan AA; Cines DB; Zhang J; Schmaier AH J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355 [TBL] [Abstract][Full Text] [Related]
17. Conformational changes in low molecular weight kininogen alters its ability to bind to endothelial cells. Hasan AA; Zhang J; Samuel M; Schmaier AH Thromb Haemost; 1995 Oct; 74(4):1088-95. PubMed ID: 8560418 [TBL] [Abstract][Full Text] [Related]
18. Bradykinin regulates the expression of kininogen binding sites on endothelial cells. Zini JM; Schmaier AH; Cines DB Blood; 1993 Jun; 81(11):2936-46. PubMed ID: 8388750 [TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Joseph K; Ghebrehiwet B; Kaplan AP Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529 [TBL] [Abstract][Full Text] [Related]
20. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis. Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]